Ondine Biomedical Inc. (OBIMF)
OTCMKTS · Delayed Price · Currency is USD
0.1700
+0.0300 (21.43%)
At close: Nov 5, 2025
Ondine Biomedical Market Cap
Ondine Biomedical has a market cap or net worth of $55.98 million as of February 12, 2026. Its market cap has decreased by -11.34% in one year.
Market Cap
55.98M
Enterprise Value
52.32M
Revenue
1.62M
Ranking
n/a
PE Ratio
n/a
Stock Price
$0.17
Market Cap Chart
Since December 6, 2021, Ondine Biomedical's market cap has decreased from 149.55M to 55.98M, a decrease of -62.57%. That is a compound annual growth rate of -20.91%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Feb 12, 2026 | 55.98M | 7.00% |
| Dec 31, 2025 | 52.32M | 17.53% |
| Dec 31, 2024 | 44.51M | 76.13% |
| Dec 29, 2023 | 25.27M | -47.42% |
| Dec 30, 2022 | 48.06M | -67.13% |
| Dec 31, 2021 | 146.23M | -2.22% |
| Dec 6, 2021 | 149.55M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| BioLargo | 55.59M |
| Leatt | 55.25M |
| Investview | 55.24M |
| ClimateRock | 55.08M |
| Apple iSports Group | 54.95M |
| TriLinc Global Impact Fund, LLC | 54.94M |
| Redwood Capital Bancorp | 54.71M |
| FFBW, Inc. | 54.54M |